SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2ei8'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 8	HIS A 57 ASP A 189 SER A 195 VAL A 213 GLY A 226	None DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A)	0.61A	1aq7A-2ei8A: 35.6	1aq7A-2ei8A: 38.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 8	HIS A 57 ASP A 189 VAL A 213 GLY A 216 GLY A 226	None DT8 A 700 (-3.5A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.48A	1aq7A-2ei8A: 35.6	1aq7A-2ei8A: 38.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	7 / 9	ASP A 189 ALA A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	DT8 A 700 (-3.5A) DT8 A 700 (-3.6A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.31A	1bcuH-2ei8A: 36.2	1bcuH-2ei8A: 40.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 9	ASP A 189 ALA A 190 VAL A 138 GLY A 226 GLY A 184	DT8 A 700 (-3.5A) DT8 A 700 (-3.6A) None DT8 A 700 (-3.5A) None	1.23A	1bcuH-2ei8A: 36.2	1bcuH-2ei8A: 40.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D4F_A_ADNA601_1 (S-ADENOSYLHOMOCYSTEI NE HYDROLASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 12	LEU A 155 THR A 73 ASP A 194 LEU A 32 GLY A 40	None	1.37A	1d4fA-2ei8A: undetectable	1d4fA-2ei8A: 19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D4F_D_ADND604_1 (S-ADENOSYLHOMOCYSTEI NE HYDROLASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 12	LEU A 155 THR A 73 ASP A 194 LEU A 32 GLY A 40	None	1.39A	1d4fD-2ei8A: undetectable	1d4fD-2ei8A: 19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_B_NCAB700_0 (EXOTOXIN A)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 6	GLY A 226 TYR A 185 ALA A 221 GLU A 188	DT8 A 700 (-3.5A) None None None	0.94A	1dmaB-2ei8A: undetectable	1dmaB-2ei8A: 19.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DWC_H_MITH1_1 (ALPHA-THROMBIN (LARGE SUBUNIT))	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 9	HIS A 57 ASP A 189 SER A 195 TRP A 215 GLY A 226	None DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A)	0.46A	1dwcH-2ei8A: 35.4	1dwcH-2ei8A: 40.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	7 / 12	HIS A 57 ASP A 189 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	None DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.60A	1etrH-2ei8A: 35.3	1etrH-2ei8A: 40.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 8	ASP A 189 GLN A 192 SER A 195 VAL A 213 GLY A 226	DT8 A 700 (-3.5A) DT8 A 700 (-3.9A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A)	0.39A	1f5lA-2ei8A: 33.5	1f5lA-2ei8A: 32.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 8	ASP A 189 SER A 195 VAL A 213 GLY A 216 GLY A 226	DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.38A	1f5lA-2ei8A: 33.5	1f5lA-2ei8A: 32.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_B_SAMB500_1 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 8	ASP A 102 PHE A 94 SER A 195 ALA A 104	None None DT8 A 700 ( 3.9A) None	1.02A	1rqpC-2ei8A: undetectable	1rqpC-2ei8A: 21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_C_SAMC500_0 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 8	ASP A 102 PHE A 94 SER A 195 ALA A 104	None None DT8 A 700 ( 3.9A) None	1.00A	1rqpA-2ei8A: undetectable	1rqpA-2ei8A: 21.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 6	ASP A 189 SER A 195 VAL A 213 GLY A 216 GLY A 226	DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.45A	1tnlA-2ei8A: 35.6	1tnlA-2ei8A: 38.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F6D_A_ACRA996_1 (GLUCOAMYLASE GLU1)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 7	HIS A 199 ASP A 189 THR A 135 GLY A 136	None DT8 A 700 (-3.5A) None None	0.87A	2f6dA-2ei8A: undetectable	2f6dA-2ei8A: 19.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 6	ASP A 189 SER A 195 VAL A 213 GLY A 216 GLY A 226	DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.28A	2otvA-2ei8A: 35.8	2otvA-2ei8A: 38.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	6 / 12	GLY A 142 GLY A 44 GLY A 196 GLY A 193 THR A 54 LEU A 53	None	1.37A	2oxtD-2ei8A: undetectable	2oxtD-2ei8A: 20.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	10 / 12	TYR A 99 PHE A 174 ASP A 189 ALA A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226 TYR A 228	DT8 A 700 (-3.4A) DT8 A 700 (-3.4A) DT8 A 700 (-3.5A) DT8 A 700 (-3.6A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.28A	2p16A-2ei8A: 46.2	2p16A-2ei8A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_2 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	3 / 3	ARG A 143 GLU A 147 GLN A 192	None None DT8 A 700 (-3.9A)	1.03A	2p16A-2ei8A: 46.2	2p16A-2ei8A: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_A_CHDA803_0 (FERROCHELATASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 5	LEU A 123 PRO A 124 LEU A 235 ILE A 238	None	0.82A	2qd4A-2ei8A: undetectable	2qd4A-2ei8A: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V7U_A_SAMA1299_0 (5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 8	ASP A 102 PHE A 94 SER A 195 ALA A 104	None None DT8 A 700 ( 3.9A) None	1.01A	2v7uA-2ei8A: undetectable	2v7uA-2ei8A: 21.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	6 / 8	ASP A 189 GLN A 192 SER A 195 VAL A 213 GLY A 216 GLY A 226	DT8 A 700 (-3.5A) DT8 A 700 (-3.9A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.47A	2vinA-2ei8A: 14.1	2vinA-2ei8A: 32.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	11 / 12	TYR A 99 PHE A 174 ASP A 189 ALA A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 218 GLY A 226 TYR A 228	DT8 A 700 (-3.4A) DT8 A 700 (-3.4A) DT8 A 700 (-3.5A) DT8 A 700 (-3.6A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A) DT8 A 700 (-4.1A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.32A	2w26A-2ei8A: 46.6	2w26A-2ei8A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	6 / 11	HIS A 57 ASP A 189 SER A 195 TRP A 215 GLY A 216 GLY A 226	None DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.53A	3gy3A-2ei8A: 35.7	3gy3A-2ei8A: 38.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 6	SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.35A	3rxfA-2ei8A: 14.1	3rxfA-2ei8A: 38.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXH_A_HSMA7_1 (CATIONIC TRYPSIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 5	ASP A 189 SER A 195 VAL A 213 GLY A 226	DT8 A 700 (-3.5A) DT8 A 700 ( 3.9A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.5A)	0.41A	3rxhA-2ei8A: 35.7	3rxhA-2ei8A: 38.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F4D_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 4	LEU A 123 PRO A 124 LEU A 235 ILE A 238	None	0.92A	4f4dB-2ei8A: undetectable	4f4dB-2ei8A: 19.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4FU8_A_ACTA302_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	4 / 5	HIS A 57 GLN A 192 GLY A 193 SER A 195	None DT8 A 700 (-3.9A) None DT8 A 700 ( 3.9A)	0.32A	4fu8A-2ei8A: 33.7	4fu8A-2ei8A: 33.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_D_15UD402_1 (PROTHROMBIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	6 / 12	HIS A 57 ASP A 189 ALA A 190 VAL A 213 TRP A 215 GLY A 226	None DT8 A 700 (-3.5A) DT8 A 700 (-3.6A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A)	0.42A	4hfpD-2ei8A: 35.1	4hfpD-2ei8A: 40.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	6 / 10	ALA A 55 THR A 54 ALA A 104 ALA A 56 GLY A 211 THR A 229	None	1.48A	4qvyK-2ei8A: undetectable 4qvyL-2ei8A: undetectable	4qvyK-2ei8A: 22.51 4qvyL-2ei8A: 23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	6 / 10	ALA A 55 THR A 54 ALA A 104 ALA A 56 GLY A 211 THR A 229	None	1.48A	4qvyY-2ei8A: undetectable 4qvyZ-2ei8A: undetectable	4qvyY-2ei8A: 22.51 4qvyZ-2ei8A: 23.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	6 / 12	HIS A 57 ALA A 190 VAL A 213 TRP A 215 GLY A 216 GLY A 226	None DT8 A 700 (-3.6A) DT8 A 700 ( 4.1A) DT8 A 700 (-3.9A) DT8 A 700 (-3.5A) DT8 A 700 (-3.5A)	0.63A	4rn6B-2ei8A: 30.0	4rn6B-2ei8A: 40.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X3M_B_ADNB301_1 (RNA 2'-O RIBOSE METHYLTRANSFERASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 9	PRO A 198 LEU A 33 ILE A 212 LEU A 53 THR A 54	None	1.14A	4x3mB-2ei8A: undetectable	4x3mB-2ei8A: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_A_SAMA301_0 (METHYLTRANSFERASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 12	GLY A 142 GLY A 196 GLY A 43 GLY A 140 PHE A 94	None	0.92A	5vimA-2ei8A: undetectable	5vimA-2ei8A: 22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_B_SAMB301_0 (METHYLTRANSFERASE)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 12	GLY A 142 GLY A 196 GLY A 43 GLY A 140 PHE A 94	None	0.94A	5vimB-2ei8A: undetectable	5vimB-2ei8A: 22.18

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"HIS A  57;ASP A 189;SER A 195;VAL A 213;GLY A 226","None;DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A)","0.61A","1aq7A-2ei8A:35.6","1aq7A-2ei8A:38.98"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"HIS A  57;ASP A 189;VAL A 213;GLY A 216;GLY A 226","None;DT8 A 700 (-3.5A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.48A","1aq7A-2ei8A:35.6","1aq7A-2ei8A:38.98"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",7,"ASP A 189;ALA A 190;SER A 195;VAL A 213;TRP A 215;GLY A 216;GLY A 226","DT8 A 700 (-3.5A);DT8 A 700 (-3.6A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.31A","1bcuH-2ei8A:36.2","1bcuH-2ei8A:40.77"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"ASP A 189;ALA A 190;VAL A 138;GLY A 226;GLY A 184","DT8 A 700 (-3.5A);DT8 A 700 (-3.6A);None;DT8 A 700 (-3.5A);None","1.23A","1bcuH-2ei8A:36.2","1bcuH-2ei8A:40.77"],["1D4F_A_ADNA601_1","S-ADENOSYLHOMOCYSTEINE HYDROLASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"LEU A 155;THR A  73;ASP A 194;LEU A  32;GLY A  40","None","1.37A","1d4fA-2ei8A:undetectable","1d4fA-2ei8A:19.72"],["1D4F_D_ADND604_1","S-ADENOSYLHOMOCYSTEINE HYDROLASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"LEU A 155;THR A  73;ASP A 194;LEU A  32;GLY A  40","None","1.39A","1d4fD-2ei8A:undetectable","1d4fD-2ei8A:19.72"],["1DMA_B_NCAB700_0","EXOTOXIN A","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"GLY A 226;TYR A 185;ALA A 221;GLU A 188","DT8 A 700 (-3.5A);None;None;None","0.94A","1dmaB-2ei8A:undetectable","1dmaB-2ei8A:19.85"],["1DWC_H_MITH1_1","ALPHA-THROMBIN (LARGE SUBUNIT)","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"HIS A  57;ASP A 189;SER A 195;TRP A 215;GLY A 226","None;DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A)","0.46A","1dwcH-2ei8A:35.4","1dwcH-2ei8A:40.77"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",7,"HIS A  57;ASP A 189;SER A 195;VAL A 213;TRP A 215;GLY A 216;GLY A 226","None;DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.60A","1etrH-2ei8A:35.3","1etrH-2ei8A:40.61"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"ASP A 189;GLN A 192;SER A 195;VAL A 213;GLY A 226","DT8 A 700 (-3.5A);DT8 A 700 (-3.9A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A)","0.39A","1f5lA-2ei8A:33.5","1f5lA-2ei8A:32.17"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"ASP A 189;SER A 195;VAL A 213;GLY A 216;GLY A 226","DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.38A","1f5lA-2ei8A:33.5","1f5lA-2ei8A:32.17"],["1RQP_B_SAMB500_1","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"ASP A 102;PHE A  94;SER A 195;ALA A 104","None;None;DT8 A 700 ( 3.9A);None","1.02A","1rqpC-2ei8A:undetectable","1rqpC-2ei8A:21.19"],["1RQP_C_SAMC500_0","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"ASP A 102;PHE A  94;SER A 195;ALA A 104","None;None;DT8 A 700 ( 3.9A);None","1.00A","1rqpA-2ei8A:undetectable","1rqpA-2ei8A:21.19"],["1TNL_A_TPAA900_1","TRYPSIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"ASP A 189;SER A 195;VAL A 213;GLY A 216;GLY A 226","DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.45A","1tnlA-2ei8A:35.6","1tnlA-2ei8A:38.98"],["2F6D_A_ACRA996_1","GLUCOAMYLASE GLU1","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"HIS A 199;ASP A 189;THR A 135;GLY A 136","None;DT8 A 700 (-3.5A);None;None","0.87A","2f6dA-2ei8A:undetectable","2f6dA-2ei8A:19.39"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"ASP A 189;SER A 195;VAL A 213;GLY A 216;GLY A 226","DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.28A","2otvA-2ei8A:35.8","2otvA-2ei8A:38.98"],["2OXT_D_SAMD300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",6,"GLY A 142;GLY A  44;GLY A 196;GLY A 193;THR A  54;LEU A  53","None","1.37A","2oxtD-2ei8A:undetectable","2oxtD-2ei8A:20.79"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",10,"TYR A  99;PHE A 174;ASP A 189;ALA A 190;SER A 195;VAL A 213;TRP A 215;GLY A 216;GLY A 226;TYR A 228","DT8 A 700 (-3.4A);DT8 A 700 (-3.4A);DT8 A 700 (-3.5A);DT8 A 700 (-3.6A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.28A","2p16A-2ei8A:46.2","2p16A-2ei8A:100.00"],["2P16_A_GG2A298_2","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",3,"ARG A 143;GLU A 147;GLN A 192","None;None;DT8 A 700 (-3.9A)","1.03A","2p16A-2ei8A:46.2","2p16A-2ei8A:100.00"],["2QD4_A_CHDA803_0","FERROCHELATASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"LEU A 123;PRO A 124;LEU A 235;ILE A 238","None","0.82A","2qd4A-2ei8A:undetectable","2qd4A-2ei8A:19.50"],["2V7U_A_SAMA1299_0","5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"ASP A 102;PHE A  94;SER A 195;ALA A 104","None;None;DT8 A 700 ( 3.9A);None","1.01A","2v7uA-2ei8A:undetectable","2v7uA-2ei8A:21.19"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",6,"ASP A 189;GLN A 192;SER A 195;VAL A 213;GLY A 216;GLY A 226","DT8 A 700 (-3.5A);DT8 A 700 (-3.9A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.47A","2vinA-2ei8A:14.1","2vinA-2ei8A:32.17"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",11,"TYR A  99;PHE A 174;ASP A 189;ALA A 190;SER A 195;VAL A 213;TRP A 215;GLY A 216;GLY A 218;GLY A 226;TYR A 228","DT8 A 700 (-3.4A);DT8 A 700 (-3.4A);DT8 A 700 (-3.5A);DT8 A 700 (-3.6A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A);DT8 A 700 (-4.1A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.32A","2w26A-2ei8A:46.6","2w26A-2ei8A:100.00"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",6,"HIS A  57;ASP A 189;SER A 195;TRP A 215;GLY A 216;GLY A 226","None;DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.53A","3gy3A-2ei8A:35.7","3gy3A-2ei8A:38.98"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"SER A 195;VAL A 213;TRP A 215;GLY A 216;GLY A 226","DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.35A","3rxfA-2ei8A:14.1","3rxfA-2ei8A:38.98"],["3RXH_A_HSMA7_1","CATIONIC TRYPSIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"ASP A 189;SER A 195;VAL A 213;GLY A 226","DT8 A 700 (-3.5A);DT8 A 700 ( 3.9A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.5A)","0.41A","3rxhA-2ei8A:35.7","3rxhA-2ei8A:38.98"],["4F4D_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"LEU A 123;PRO A 124;LEU A 235;ILE A 238","None","0.92A","4f4dB-2ei8A:undetectable","4f4dB-2ei8A:19.78"],["4FU8_A_ACTA302_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",4,"HIS A  57;GLN A 192;GLY A 193;SER A 195","None;DT8 A 700 (-3.9A);None;DT8 A 700 ( 3.9A)","0.32A","4fu8A-2ei8A:33.7","4fu8A-2ei8A:33.46"],["4HFP_D_15UD402_1","PROTHROMBIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",6,"HIS A  57;ASP A 189;ALA A 190;VAL A 213;TRP A 215;GLY A 226","None;DT8 A 700 (-3.5A);DT8 A 700 (-3.6A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A)","0.42A","4hfpD-2ei8A:35.1","4hfpD-2ei8A:40.38"],["4QVY_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",6,"ALA A  55;THR A  54;ALA A 104;ALA A  56;GLY A 211;THR A 229","None","1.48A","4qvyK-2ei8A:undetectable;4qvyL-2ei8A:undetectable","4qvyK-2ei8A:22.51;4qvyL-2ei8A:23.19"],["4QVY_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",6,"ALA A  55;THR A  54;ALA A 104;ALA A  56;GLY A 211;THR A 229","None","1.48A","4qvyY-2ei8A:undetectable;4qvyZ-2ei8A:undetectable","4qvyY-2ei8A:22.51;4qvyZ-2ei8A:23.19"],["4RN6_B_15UB301_1","THROMBIN HEAVY CHAIN","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",6,"HIS A  57;ALA A 190;VAL A 213;TRP A 215;GLY A 216;GLY A 226","None;DT8 A 700 (-3.6A);DT8 A 700 ( 4.1A);DT8 A 700 (-3.9A);DT8 A 700 (-3.5A);DT8 A 700 (-3.5A)","0.63A","4rn6B-2ei8A:30.0","4rn6B-2ei8A:40.38"],["4X3M_B_ADNB301_1","RNA 2'-O RIBOSE METHYLTRANSFERASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"PRO A 198;LEU A  33;ILE A 212;LEU A  53;THR A  54","None","1.14A","4x3mB-2ei8A:undetectable","4x3mB-2ei8A:20.22"],["5VIM_A_SAMA301_0","METHYLTRANSFERASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"GLY A 142;GLY A 196;GLY A  43;GLY A 140;PHE A  94","None","0.92A","5vimA-2ei8A:undetectable","5vimA-2ei8A:22.18"],["5VIM_B_SAMB301_0","METHYLTRANSFERASE","2ei8","COAGULATION FACTOR X, HEAVY CHAIN","Homo sapiens",5,"GLY A 142;GLY A 196;GLY A  43;GLY A 140;PHE A  94","None","0.94A","5vimB-2ei8A:undetectable","5vimB-2ei8A:22.18"]]